https://investingnews.com/rezolute-provides-update-on-its-congenital-hyperinsulinism-program-following-fda-meeting/
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting | INN
Mar 24, 2026 - Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of...
congenital hyperinsulinism
https://www.chop.edu/centers-programs/congenital-hyperinsulinism-center/patient-stories?page=2
Congenital Hyperinsulinism Center Patient Stories | Children's Hospital of Philadelphia
Read stories about patients who have been cared for by the Congenital Hyperinsulinism Center
children s hospitalcongenital hyperinsulinismpatient storiescenterphiladelphia
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1549310/full
Frontiers | Developing a congenital hyperinsulinism prioritized research agenda: a patient-driven...
IntroductionCongenital Hyperinsulinism (HI) is a rare disease that causes severe and recurrent hypoglycemia due to dysregulated insulin secretion. HI is the ...
congenital hyperinsulinismresearch agendafrontiersdevelopingpatient
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2018.00619/full
Frontiers | Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With...
BACKGROUND: Congenital Hyperinsulinism (CHI) is an important cause of severe and persistent hypoglycaemia in infancy and childhood. The focal form (CHI-F) o...
congenital hyperinsulinismfrontiersclinicaldiversityfocal
https://www.chop.edu/centers-programs/congenital-hyperinsulinism-center/research-studies?page=1
Congenital Hyperinsulinism Center Research Studies | Children's Hospital of Philadelphia
children s hospitalcongenital hyperinsulinismresearch studiescenterphiladelphia
https://www.chop.edu/centers-programs/congenital-hyperinsulinism-center/refer-patient-congenital-hyperinsulinism-hi
Refer a Patient With Congenital Hyperinsulinism (HI) | Children's Hospital of Philadelphia
To refer a patient, contact the the HI Center by phone or online, send a specimen for mutation analysis, and initiate precertification from the insurance...
refer a patientchildren s hospitalcongenital hyperinsulinism
https://www.chop.edu/conditions-diseases/congenital-hyperinsulinism/research-studies
Congenital Hyperinsulinism Research Studies | Children's Hospital of Philadelphia
children s hospitalcongenital hyperinsulinismresearch studiesphiladelphia
https://investingnews.com/rezolute-provides-insights-from-its-phase-3-sunrize-study-in-congenital-hyperinsulinism-and-shares-findings-from-its-expanded-access-program-in-tumor-hyperinsulinism/
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares...
Jan 12, 2026 - Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in both indications Company plans to...